Drug Details
Therapeutic Class:
Sodium-glucose co-transporter 2 (SGLT2) inhibitor
Forms:
Tablet
Administration:
By mouth
Therapeutic Uses:
- Type 2 diabetes mellitus
- Lowers the risk of heart failure hospitalization and cardiovascular death in people with diabetes, established cardiovascular disease, or multiple cardiovascular risk factors
- Lowers the risk of cardiovascular death in certain people with heart failure or chronic kidney disease
Controlled Status:
Not a controlled substance
Farxiga Drug Class
Farxiga (far zee guh) belongs to a group of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors.
Farxiga Age Range
Farxiga is approved for use in adults. The safety and effectiveness of Farxiga in pediatric patients (under 18) have not been established.
SOCIAL